A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients.

Jonathan McCafferty,Kartikey Grover,Li Li,Zhiqiang Li,Marc Y. Fink,Howard Goldsweig,Meng Ma,Xiang Zhou,Tommy Mullaney,Arielle Redfern,Whitney Jappe,Michelle Zimmerman,Tony Prentice,Qi Pan,William Oh,Eric E. Schadt,Dan Li,Rong Chen

A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients.

2019

Jonathan McCafferty
Kartikey Grover
Li Li
Zhiqiang Li
Marc Y. Fink
Howard Goldsweig
Meng Ma
Xiang Zhou
Tommy Mullaney
Arielle Redfern
Whitney Jappe
Michelle Zimmerman
Tony Prentice
Qi Pan
William Oh
Eric E. Schadt
Dan Li
Rong Chen

e18031Background: Off-label drug use is common in cancer treatment (tx) due to limited approved tx options. Systematic analysis of RWD for off-label drug use facilitates hypothesis generation and d...

Keywords:

Alternative medicine
Off-label use
Physical therapy
Cancer
Medicine
Drug
cancer treatment
real world data
Intensive care medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations